Health systems have suffered from fragmentation, an aging population, infrastructure challenges, resource constraints, and the spread of noncommunicable diseases.
Latin American health systems have suffered from several specific factors in recent years: fragmentation, an aging population, infrastructure challenges, limited resources, the spread of non-communicable diseases, in addition to the challenges posed by the COVID-19 pandemic. we left; However, the convergence of medical knowledge and technology has the potential to revolutionize healthcare towards a digital, personal and data-driven framework.
In light of this, p (Future Proofing Healthcare) has been developed, a public policy tool aimed at decision makers and the health community that seeks to create a frame of reference to provide practical knowledge that contributes to strengthening health systems planning.
This indicator also makes it possible to contribute to the assessment of countries’ progress towards more sustainable, personalized, integrated and data-driven systems, and to identify areas for improvement in service delivery.
The index results are based on real evidence to provide an overview of the current state of personalized medicine in health systems in Argentina, Brazil, Chile, Colombia, Costa Rica, Ecuador, Mexico, Panama, Peru and Uruguay. Although the results reveal opportunities for growth in health services, a sustained high performance in personal technologies is observed across Latin America.
In the case of Mexico, the country ranked fourth in the index, as one of the countries in the region with the best conditions for incorporating and promoting personalized medicine in the future from a more effective preventive, diagnostic and therapeutic approach to each patient, according to the FutureProofing Healthcare and Roche laboratories.
In this system, it is also implemented with the contribution of independent experts, patient groups, representatives of health systems and academics in the region,
Among the practices that emerged in the index for Mexico to fill this position: the use of electronic medical records, patients’ access to their personal data, and the promotion and leadership in the publication of medical articles on the personalization of patient care. Health, advances in the use of technology in the provision of medical services, such as telemedicine, and political will for public-private partnerships.
“Rethinking personal health systems, especially in regions such as Latin America, can be challenging because there are a large number of challenges to overcome. However, using data to support treatment decisions and investments, as well as providing personalized or health-based healthcare data, promotes better clinical outcomes that improve quality of life and efficiency by delivering more integrated and humane healthcare, which translates into tangible benefit for society,” commented Dr. Mariette Perez, Medical Director of Roche Mexico.
The Personalized Medicine Index combines core elements of Roche’s vision for a better future for health, including treatment innovation, technological advances, an understanding of human biology, and the ability to analyze data to transform the promise of personalized medicine.
Through 33 indicators, grouped into four pillars: health information, personalized technology, health policy and service context; This tool seeks to measure the progress of healthcare towards a more personalized, digital and data-driven standard.
The launch of the index in Latin America is an integral part of the global Roche initiative, which has successfully launched the index in other regions such as Asia Pacific and Europe, as part of its commitment to continue its efforts to create benchmarks and evaluate what is prepared for it. For the future countries of the region and other parts of the world.